Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with epithelial ovarian cancer, which includes specific types such as high- and low-grade serous, high- and low-grade endometrioid, mucinous, and carcinosarcoma.
- People whose cancer has been staged anywhere from stage IA to stage IVB (covering early through advanced stages) using the FIGO 2014 staging system.
- People who are having their main surgery for the first time, or who are having surgery after completing 3–4 or 6 cycles of chemotherapy beforehand.
- People who had no cancer remaining after their surgery (complete removal of all visible disease).
- People who are in good general health and able to carry out normal daily activities, as measured by a standard health scale called ECOG performance status 0–1.
Who may not be able to join:
- People whose ovarian cancer is not of the epithelial type.
- People whose general health is more significantly affected, as measured by an ECOG performance status of 2–4.
- People who do not give their consent to take part in the study.
- People who did not have a full staging surgery — which includes removal of the uterus, both fallopian tubes and ovaries, lymph nodes in the pelvis and around the main abdominal artery, and the fatty tissue covering the abdominal organs (omentum) — or who had cancer remaining after surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34620151146
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
metastasis in infundibulopelvic ligament
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.